Form D · Biotechnology

Helocyte, Inc.

New York, NY · CIK 0001679808

Offering snapshot reported Nov 4, 2016 · SEC filing

Reported sold
$4M
Offering amount: $5M
Investors reported
61
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 31, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2M$4MJul 15, 2016: $1,000,000.00Jul 15, 2016Oct 14, 2016: $3,018,000.00Oct 14, 2016Nov 4, 2016: $3,998,000.00Nov 4, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,018,000 → $3,998,000
  • Reported investors34 → 61

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 4, 2016Amendment$3,998,000$980,000vs Oct 14, 201661SEC filing
Oct 14, 2016Amendment$3,018,000$2,018,000vs Jul 15, 201634SEC filing
Jul 15, 2016Initial$1,000,000No comparison11SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$400K
Finders' fees
$0
Form D file number
021-267116

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Aegis Capital Corp.15007Aegis Capital Corp. · CRD 15007

Source: Form D, filed Nov 4, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth W. Cappell Director
David J. Horin Executive
Elizabeth Clark Moore Executive
Lindsay A. Rosenwald Director
Frank Taffy Director, Executive
Michael S. Weiss Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2 Gansevoort Street 9 Th Floor
New York, NY, 10014